
Cellular Matrix A-CP-HA
Synergistically combines the complementary clinical effects of PRP and HA to provide added benefit for OA patients.
A-PRP: The patient’s platelet concentrate prepared with Cellular Matrix, provides an autologous reservoir of growth factors.
CellularMatrix A-CP-HA – Medical Device Class III – CE2797. Fully license to used as combination therapeutic, Cellular Matrix is a cell-friendly network that contains 2ml of HA at a concentration of 20mg/ml (40mg total), in addition to the thixotropic cell-separation gel and the sodium citrate anticoagulant solution.
- SKUs
- Clinical Studies
Author
Title
Link
“Is the Combination of Platelet-Rich Plasma and Hyaluronic Acid the Best Injective Treatment for Grade II-III Knee Osteoarthritis? A Prospective Study,” Advances in Orthopedics, 2023, pp. 1–6.




